|
|
 |
|
Viewing report
|
|
|
|
Pharmacoeconomics and Outcome Assessment - A Global Issue
Euromed Communications Ltd, Jan 1999, Pages: 168
Spurred on by requirements for pharmaceutical companies to demonstrate value for money from healthcare intervention, the pharmaceutical industry is having to increase its activities in the economic evaluation of medicines and quality of life assessment. To do this effectively and efficiently there is a need to train both marketing executives and clinical researchers in techniques of pharmacoeconomics.
This book shows the vital and increasing role pharmacoeconomics plays now and in the future of the pharmaceutical industry. Written by international experts in their fields, the book gives an invaluable insight into this new and exciting discipline. First published in 1999, the subject matter is still topical and may appeal to American companies affected by healthcare costs.
Customers who bought this item also bought
Pharmacoeconomic Analysis in R&D Decision Making
International Trends in the Use of Health Technology Assessment
Alzheimer Disease - New Drugs, Markets and Companies
Special Report: Successes and Lessons Learned in the Pharmaceutical Industry, 2009
Special Report: The Pricing and Reimbursement Environment for Autoimmune Biologics
Opportunities in Emerging Markets - Central and Eastern Europe, Russia, and Ukraine
Pharma Pricing and Reimbursement Outlook: Optimizing Price and Market Access in a Recessionary Climate
Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2011 Edition
The Pharmacoeconomics Outlook: Turning Value-For-Money Requirements Into A Competitive Advantage
Pharmaceutical Pricing and Reimbursement - Reference Pricing and Economic Evaluations Will Dominate Future Pricing and Reimbursement Strategies
|
|
|
|
